Cargando…

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis

Current evidence suggests that beta-blocker lower the risk of development of atrial fibrillation (AF) and in-hospital stroke after cardiac surgery. This study was to assess whether beta-blockers could decrease incidence of new-onset AF in patients with end stage renal disease (ESRD). We identified p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ting-Tse, Chiang, Jiun-Yang, Liao, Min-Tsun, Tsai, Chia-Ti, Hwang, Juey Jen, Chiang, Fu-Tien, Lin, Jiunn-Lee, Lin, Lian-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672347/ https://www.ncbi.nlm.nih.gov/pubmed/26643783 http://dx.doi.org/10.1038/srep17731

Ejemplares similares

Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
por: Chiang, Jiun-Yang, et al.
Publicado: (2020)

Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2016)

Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis: A Forgotten Risk Factor
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis
por: Chiang, Jiun-Yang, et al.
Publicado: (2016)

Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillation
por: Tsai, Chia-Ti, et al.
Publicado: (2016)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Correlation Between CHA(2)DS(2)-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study
por: Tsai, Chin-Feng, et al.
Publicado: (2021)

CHA2DS2VASc score predicts risk of end stage renal disease in patients with atrial fibrillation: Long-term follow-up study
por: Huang, Pang-Shuo, et al.
Publicado: (2023)

Alterations of sympathetic dynamics after atrial fibrillation ablation by analysis sympathetic nerve activity provide prognostic value for recurrence and mechanistic insights into ablation
por: Chen, Jien-Jiun, et al.
Publicado: (2022)

Inactivation of Myosin Binding Protein C Homolog in Zebrafish as a Model for Human Cardiac Hypertrophy and Diastolic Dysfunction
por: Chen, Yau‐Hung, et al.
Publicado: (2013)

Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation
por: Chang, Sheng‐Nan, et al.
Publicado: (2023)

Age and CHADS(2) Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation
por: Hung, Chen-Ying, et al.
Publicado: (2015)

Beta-blockers in atrial fibrillation—trying to make sense of unsettling results
por: Meyer, Markus, et al.
Publicado: (2023)

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Use of nicorandil is associated with increased risk of incident atrial fibrillation
por: Lee, Chien-Chang, et al.
Publicado: (2022)

Copy number variation of gasdermin D gene is associated with atrial fibrillation-related thromboembolic stroke
por: Huang, Pang-Shuo, et al.
Publicado: (2023)

Renal Denervation Decreases Susceptibility to Arrhythmogenic Cardiac Alternans and Ventricular Arrhythmia in a Rat Model of Post-Myocardial Infarction Heart Failure
por: Chang, Sheng-Nan, et al.
Publicado: (2017)

Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
por: Watanabe, Hiroshi, et al.
Publicado: (2018)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Habel, Nicole, et al.
Publicado: (2023)

Anti‐Inflammatory and Antiarrhythmic Effects of Beta Blocker in a Rat Model of Rheumatoid Arthritis
por: Lin, Ting‐Tse, et al.
Publicado: (2020)

Prevention of perioperative atrial fibrillation with beta blockers in elderly patient during abdominal surgery
por: Pagano, Gennaro, et al.
Publicado: (2013)

Effect of beta blockers on the incidence of atrial fibrillation in elderly patients after abdominal surgery
por: Pagano, Gennaro, et al.
Publicado: (2013)

The impact of beta-blocker use on postoperative atrial fibrillation after aortic valve replacement
por: Kim, Sue Hyun, et al.
Publicado: (2020)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
por: Yang, Yanhua, et al.
Publicado: (2020)

Genome-Wide Copy Number Variation Association Study of Atrial Fibrillation Related Thromboembolic Stroke
por: Hsieh, Chia-Shan, et al.
Publicado: (2019)

Data for rate versus rhythm control strategy on stroke and mortality in patients with atrial fibrillation
por: Weng, Chi-Jen, et al.
Publicado: (2018)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat model
por: Hassan, Hebah, et al.
Publicado: (2020)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study
por: Liao, Min-Tsun, et al.
Publicado: (2021)

Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury
por: Shiao, Chih-Chung, et al.
Publicado: (2018)

Agreement Between Automated and Human Measurements of Heart Rate in Patients With Atrial Fibrillation
por: Lin, Ting-Tse, et al.
Publicado: (2018)

Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
por: Lai, Chao‐Lun, et al.
Publicado: (2017)

Meta-analysis of the benefit of beta-blockers for the reduction of isolated atrial fibrillation incidence after cardiac surgery
por: Masuda, Yoshio, et al.
Publicado: (2020)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
por: Lin, Shan-Ju, et al.
Publicado: (2023)

Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation
por: Lin, Lian-Yu, et al.
Publicado: (2016)

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
por: Vlachopoulou, Dimitra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4i8a88l1rqr8slgucllfqgbmos